WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012095463) OXAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/095463    International Application No.:    PCT/EP2012/050387
Publication Date: 19.07.2012 International Filing Date: 11.01.2012
IPC:
C07D 413/12 (2006.01), C07D 471/04 (2006.01), A61K 31/5377 (2006.01), A61K 31/437 (2006.01), A61K 31/444 (2006.01), A61K 31/497 (2006.01), A61P 25/00 (2006.01)
Applicants: NOVARTIS AG [CH/CH]; Lichtstrasse 35 CH-4056 Basel (CH) (For All Designated States Except US).
HURTH, Konstanze [DE/CH]; (CH) (For US Only).
LUEOEND, Rainer Martin [CH/CH]; (CH) (For US Only).
MACHAUER, Rainer [DE/CH]; (CH) (For US Only).
NEUMANN, Ulf [DE/CH]; (CH) (For US Only).
RUEEGER, Heinrich [CH/CH]; (CH) (For US Only).
SCHAEFER, Michael [DE/CH]; (CH) (For US Only).
TINTELNOT-BLOMLEY, Marina [DE/CH]; (CH) (For US Only).
VEENSTRA, Siem Jacob [NL/CH]; (CH) (For US Only).
VOEGTLE, Markus [DE/CH]; (CH) (For US Only)
Inventors: HURTH, Konstanze; (CH).
LUEOEND, Rainer Martin; (CH).
MACHAUER, Rainer; (CH).
NEUMANN, Ulf; (CH).
RUEEGER, Heinrich; (CH).
SCHAEFER, Michael; (CH).
TINTELNOT-BLOMLEY, Marina; (CH).
VEENSTRA, Siem Jacob; (CH).
VOEGTLE, Markus; (CH)
Agent: CAMPBELL, Lachlan; Novartis Pharma AG Patent Department CH-4002 Basel (CH)
Priority Data:
61/432,037 12.01.2011 US
Title (EN) OXAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
(FR) DÉRIVÉS D'OXAZINE ET LEUR UTILISATION DANS LE TRAITEMENT DE TROUBLES NEUROLOGIQUES
Abstract: front page image
(EN)The invention relates to novel heterocyclic compounds of the formula (I), in which all of the variables are as defined in the specification, in free form or in pharmaceutically acceptable salt form, to their preparation, to their medical use and to medicaments comprising them.
(FR)L'invention porte sur de nouveaux composés hétérocycliques représentés par la formule (I), dans laquelle formule toutes les variables sont telles que définies dans la description, sous forme libre ou sous forme de sel pharmaceutiquement acceptable, sur leur préparation, sur leur utilisation médicale et sur des médicaments les comprenant.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)